This company has been acquired
VPAH.F Stock Overview
Provides breast imaging analytics software products in New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Volpara Health Technologies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.74 |
| 52 Week High | AU$0.89 |
| 52 Week Low | AU$0.41 |
| Beta | 1.67 |
| 1 Month Change | 24.89% |
| 3 Month Change | 23.03% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 34.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| VPAH.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -0.3% |
| 1Y | n/a | 11.6% | 8.1% |
Return vs Industry: Insufficient data to determine how VPAH.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how VPAH.F performed against the US Market.
Price Volatility
| VPAH.F volatility | |
|---|---|
| VPAH.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 11.6% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: VPAH.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine VPAH.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 156 | Teri Thomas | www.volparahealth.com |
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients’ risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast, lung, ovarian, and colorectal cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products; and Volpara Thumbnail, an image-enhanced patient notification letters.
Volpara Health Technologies Limited Fundamentals Summary
| VPAH.F fundamental statistics | |
|---|---|
| Market cap | US$194.21m |
| Earnings (TTM) | -US$5.46m |
| Revenue (TTM) | US$23.22m |
8.4x
P/S Ratio-35.6x
P/E RatioIs VPAH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VPAH.F income statement (TTM) | |
|---|---|
| Revenue | NZ$37.96m |
| Cost of Revenue | NZ$2.93m |
| Gross Profit | NZ$35.03m |
| Other Expenses | NZ$43.95m |
| Earnings | -NZ$8.92m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.035 |
| Gross Margin | 92.27% |
| Net Profit Margin | -23.50% |
| Debt/Equity Ratio | 0% |
How did VPAH.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/05/22 11:47 |
| End of Day Share Price | 2024/05/01 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2023/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Volpara Health Technologies Limited is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| John Hester | Bell Potter |
| Russell Wright | Maqro Capital |